R&D Partner Content Unlocking the Potential of Targeting the Innate Immune Syste... Ready to Catalyze the Next Wave of Inflammasome Therapies?
Market Access Partner Content The Inaugural Market Access for CNS Therapeutics Summit Has ... The only dedicated forum focused on tackling the unique commercial and reimbursement challenges facing treatments for neurodegeneration...
Partner Content Partner Content 5th Oligonucleotides for CNS Summit The Oligonucleotides for CNS Summit returns for its 5th year to address key challenges in durability, scalability, potency and CNS tropism
R&D Partner Content 2nd ADC & Novel Conjugates Partnering & Investment Summit Refine your strategy, sharpen your positioning, and meet the right partners - all at the most efficient networking event of the ADCconference calendar
R&D Partner Content Network With EHS Professionals - EHS&S for Biopharma West Advancing Biosafety & Sustainability in R&D & Manufacturing
R&D Partner Content Welcome to the 2nd Raw Materials for Cell & Gene Therapy Sum... Streamline Supply Chain Communications to Optimize Phase Appropriate QC Testing, Comparability & GMP Manufacturing of Raw Materials...
News Kidney biotech R1's $78m debut, and other biofinancings Biofinancing values have tailed off a bit after a strong start to 2026, but March has seen $50m+ rounds for R1, Crossbow, Excalipoint, and Prolium.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
